Abstract
Biotechnology Law ReportVol. 39, No. 4 As presented by Chris HolmanEagle Pharm. Inc. v. Slayback Pharma LLC United States Court of Appeals of the Federal Circuit, 2020 958 F.3d 1171Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:17 Aug 2020https://doi.org/10.1089/blr.2020.29186.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 39Issue 4Aug 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Eagle Pharm. Inc. v. Slayback Pharma LLC United States Court of Appeals of the Federal Circuit, 2020 958 F.3d 1171.Biotechnology Law Report.Aug 2020.328-331.http://doi.org/10.1089/blr.2020.29186.cmhPublished in Volume: 39 Issue 4: August 17, 2020Online Ahead of Print:July 8, 2020PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
